MPC vs MXCT · P/E 16, rev $138.86B vs rev $38.6M
Marathon Petroleum Corp (MPC) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the MPC and MXCT stock pages for the full models.
Not investment advice.